| 25532599 | p21, p53, TP53BP1 and p73 polymorphisms and the risk of gastric cardia adenocarcinoma in a Chinese population. | Biomarkers | 2015 Mar | Shao A | doi: 10.3109/1354750X.2014.996607 |
| 19806024 | DNA damage foci in mitosis are devoid of 53BP1. | Cell Cycle | 2009 Oct 15 | Nelson G | - |
| 23027628 | 53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-??B through miR-146a. | Carcinogenesis | 2012 Dec | Li X | doi: 10.1093/carcin/bgs298 |
| 27613518 | 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. | BMC Cancer | 2016 Sep 9 | Hong R | doi: 10.1186/s12885-016-2754-7. |
| 28930533 | 53BP1: A guardian for centrosomal integrity. | Front Biosci (Landmark Ed) | 2018 Jan 1 | Kim H | - |
| 30002377 | Molecular basis for the inhibition of the methyl-lysine binding function of 53BP1 by TIRR. | Nat Commun | 2018 Jul 12 | Wang J | doi: 10.1038/s41467-018-05174-9. |
| 22266878 | 53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway. | Oncol Rep | 2012 Apr | Hong S | doi: 10.3892/or.2012.1641 |
| 26011542 | 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. | Cancer Sci | 2015 Aug | Kong X | doi: 10.1111/cas.12699 |
| 26615718 | Functional crosstalk between DNA damage response proteins 53BP1 and BRCA1 regulates double strand break repair choice. | Radiother Oncol | 2016 May | Bakr A | doi: 10.1016/j.radonc.2015.11.001 |
| 12170762 | Mutations in the p53 tumor suppressor gene and early onset breast cancer. | Cancer Biol Ther | 2002 Jan-Feb | Lai H | - |
| 24681733 | The staining patterns of 53BP1 nuclear foci and 53BP1 mRNA level are associated with cervical cancer progression and metastasis. | Int J Gynecol Pathol | 2014 May | Zhu H | doi: 10.1097/PGP.0000000000000079. |
| 21635553 | Genetic polymorphisms of TP53-binding protein 1 (TP53BP1) gene and association with breast cancer risk. | APMIS | 2011 Jul | Naidu R | doi: 10.1111/j.1600-0463.2011.02753.x |
| 24603722 | Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis. | PLoS One | 2014 Mar 6 | Liu L | doi: 10.1371/journal.pone.0090931 |
| 22323184 | The role of ATM and 53BP1 as predictive markers in cervical cancer. | Int J Cancer | 2012 Nov 1 | Roossink F | doi: 10.1002/ijc.27488 |
| 27466483 | Efficacy of the Combination of a PARP Inhibitor and UVC on Cancer Cells as Imaged by Focus Formation by the DNA Repair-related Protein 53BP1 Linked to Green Fluorescent Protein. | Anticancer Res | 2016 Aug | Tome Y | - |
| 12646190 | P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. | Biochem Biophys Res Commun | 2003 Mar 28 | Yan DH | - |
| 27465548 | DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer. | Tumour Biol | 2016 Oct | Cirauqui B | - |
| 26261485 | Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer. | Int J Clin Exp Pathol | 2015 Jun 1 | Bi J | - |
| 24316395 | Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese. | Arch Med Res | 2014 Jan | Zhang H | doi: 10.1016/j.arcmed.2013.10.011 |
| 17634560 | Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck. | Clin Cancer Res | 2007 Jul 15 | Chen K | - |
| 26637364 | High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer. | Mol Cancer Ther | 2016 Jan | Schouten PC | doi: 10.1158/1535-7163.MCT-15-0470 |
| 20372852 | Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. | Oncol Rep | 2010 May | Kiyohara C | - |
| 23680719 | Radiation-dose response of glycophorin A somatic mutation in erythrocytes associated with gene polymorphisms of p53 binding protein 1. | Mutat Res | 2013 Jul 4 | Yoshida K | doi: 10.1016/j.mrgentox.2013.05.003 |
| 26541290 | A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome. | BMC Cancer | 2015 Nov 6 | Djuzenova CS | doi: 10.1186/s12885-015-1890-9. |
| 20686496 | Genetic variants in the 53BP1 gene and skin cancer risk. | J Invest Dermatol | 2010 Dec | He C | doi: 10.1038/jid.2010.227 |
| 24191908 | BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. | BMC Cancer | 2013 Nov 5 | Jacot W | doi: 10.1186/1471-2407-13-523. |
| 27499037 | Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer. | Int J Oncol | 2016 Oct | Xiao Y | doi: 10.3892/ijo.2016.3629 |
| 29445165 | 53BP1 can limit sister-chromatid rupture and rearrangements driven by a distinct ultrafine DNA bridging-breakage process. | Nat Commun | 2018 Feb 14 | Tiwari A | doi: 10.1038/s41467-018-03098-y. |
| 28475402 | DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis. | Cancer Biol Ther | 2017 Jun 3 | De Gregoriis G | doi: 10.1080/15384047.2017.1323590 |
| 30082159 | Intratumoral heterogeneity for frameshift mutations of TP53BP1 and MFN1 genes in colorectal cancers. | Pathol Res Pract | 2018 Sep | Choi EJ | doi: 10.1016/j.prp.2018.07.024 |
